-
公开(公告)号:EP0439453B1
公开(公告)日:1994-01-19
申请号:EP88908644.3
申请日:1988-09-29
申请人: Exomed Australia Pty. Ltd. (ACN 051 976 446) , Ostapat Pty. Ltd. (ACN 003 660 759) , Gastro Services Pty. Limited (ACN 002 994 890) , Capability Services Pty. Limited (ACN 003 015 227)
发明人: Exomed Australia Pty. Ltd. (ACN 051 976 446) , Ostapat Pty. Ltd. (ACN 003 660 759) , Gastro Services Pty. Limited (ACN 002 994 890) , Capability Services Pty. Limited (ACN 003 015 227)
CPC分类号: A61K31/70 , A61K33/245 , Y10S514/925 , A61K33/24 , A61K31/29 , A61K2300/00
摘要: The present invention provides a method for eradicating and/or preventing recurrence of gastrointestinal disorders associated with Campylobacter pylori infections, which involves the administration of a pharmaceutical composition, comprising a pharmaceutically acceptable bismuth compound with a first antibiotic and a second antibiotic. There is also provided a pharmaceutical composition for the treatment of gastrointestinal disorders associated with C. pylori, and pharmaceutical compositions for said treatment in the form of a sequential pack.
-
公开(公告)号:EP0433299B1
公开(公告)日:1998-05-06
申请号:EP89909128.4
申请日:1989-08-02
IPC分类号: A61K39/02 , A61K39/08 , A61K39/10 , A61K39/114 , A61K35/24
CPC分类号: A61K35/741 , A61K35/742 , A61K35/744 , A61K35/745 , A61K35/747 , Y02A50/473 , A61K2300/00
摘要: A method of treating chronic disorders associated with the presence of abnormal microflora or an abnormal distribution of microflora in the gastrointestinal tract. The method involves the removal of at least a portion of the host's existing enteric microflora and the substitution of an effective amount of predetermined microflora. Pharmaceutical compositions which comprise viable microorganisms in a composition resembling the host's normal healthy faecal flora are also disclosed.
-